plus L-phenylalanine in the treatment of depression
J Neural Transmission. (AUSTRIA), 1984, 59/1 (81-87)
The antidepressive efficacy of deprenyl (5-10 mg daily) plus L-phenylalanine (205
mg/day) has been evaluated in 155 unipolar depressed patients.
Both oral and intravenous
administration showed beneficial effects in 90% of outpatients
and 80.5% of inpatients. It is concluded that this combined treatment has a potent
antidepressive action based on the accumulation of L-phenylethylamine in the brain.